0009

China Resources Sanjiu Medical & Pharmaceutical Co Ltd

000999.SHE 999.com.cn + Research + Basket
ISIN CNE0000011K8
Employees 30,304
Phone 86 755 8336 0999
Fiscal year end December
IPO Nov 11, 1999
Address Guanlan High-tech Park, Shenzhen, China, 518110
25.69
-0.26 (-1.00%)
CNY · SHE
52-week range
21.25
29.42
Trading at 54% of the 52-week range
Market Cap
43.19B
P/E Ratio
13.38
Forward P/E
16.47
Book Value
13.60
Div. Yield
3.88%
% Institutions
5.71%
% Insiders
64.85%

1 Year

-11.5%

3 Year

+11.8%

10 Year

+100.6%
Description

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese medicine health products; and vitamins, minerals, protein powder, collagen, probiotics, health foods, and formula granules. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. was incorporated in 1999 and is headquartered in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited.

Actions

Add an action for 000999.SHE, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Wen Duo Wu President & Director 1974
Mr. Jian Xing CFO & Secretary of the Board 1978
Mr. Yi Mai Vice President 1967
Mr. Liang Wang Vice President 1979
Mr. Ke Wang Vice President 1974
Mr. Yu Xiang Vice President 1981

Financial Highlights

▼
Market Cap: $43.19B
EBITDA: $5.74B
P/E Ratio: $13.38
PEG Ratio: $1.38
Book Value: $13.60
Dividend/Share: $1.01
Dividend Yield: 3.88%
Earnings/Share: $1.94
Profit Margin: 10.40%
Operating Margin: 15.04%
ROA (TTM): 4.93%
ROE (TTM): 10.16%
Revenue (TTM): $31.03B
Revenue/Share (TTM): $18.66
Earnings Growth (YOY): -9.30%
Revenue Growth (YOY): -10.90%

Valuation Metrics

Enterprise Value: $40.17B
Trailing P/E: 13.38
Forward P/E: 16.47

Shares Statistics

Shares Outstanding: 1.66B
Shares Float: 563.37M
% Insiders: 64.85%
% Institutions: 5.71%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$31.60B
Cost of Goods Sold
adjust
$-14.57B
Gross Profit
subtotal
$17.04B
SG&A
adjust
$-1.86B
R&D
adjust
$-1.34B
Other Operating Expense
adjust
$-8.98B
Operating Income
subtotal
$4.85B
Other / Non-Operating Items
adjust
$-1.43B
Net Income
subtotal
$3.42B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 000999.SHE!